Articles Vol. 66 No. CĐ9-NCKH 22/08/2025

2. CLINICAL AND CEREBROSPINAL FLUID RESPONS IN PATIENT WITH TUBERCULOUS MENINGITIS DURING THE FIRST MONTH OF TREATMENT AT NATIONAL LUNG HOSPITAL IN 2017

Nguyen Ngoc Truong Thi1,2, Nguyen Thu Ha1,2
1 National Lung Hospital
2 Bệnh viện Phổi Trung ương
Corresponding author: thify268@gmail.com
DOI: 10.52163/yhc.v66iCD9.2668
26 Views
18 Downloads
Keywords
Viêm màng não lao dịch não tủy đáp ứng điều trị chọc dịch não tủy.
Abstract

Introduction: Tuberculosis meningitis remains a difficult disease to diagnose and treatment with a mortality rate of about 30%, and often leaves serious neurological sequelae. The respone of treament in patients with tuberculosis meningitis after initiation of anti-tuberculosis therapy is unclear.

Objective: To evaluate clinical and cerebrospinal fluid response in patients with tuberculous meningitis during the first month of treatment at National Lung Hospital.

Materials and methods: Conducted an observational study to evaluate the response within 30 days of treatment in patients with tuberculosis meningitis. All patients (n = 43) were treated with anti-tuberculosis drugs (Streptomycin, Rifampicin, Isoniazid, Pyrazinamide, Ethambutol) in combination with corticosteroids. Patients were monitored for clinical symptoms, laboratory tests, and cerebrospinal fluid.

Results: The clinical symptoms improved early after 15 days were fever (65.1% to 30.2%), vomiting, nausea (39.5% to 9.3%), consciousness disturbance (62.8% to 44.2%), meningeal signs (97.7% to 74.4%). The symptoms improved after 30 days were headache (90.3% to 55.8%) and round muscle disorder (48.8% to 11.6%). The mean cerebrospinal fluid leukocyte decreased after 30 days (496 ± 539 to 237 ± 273 cells/mm3), but mean cerebrospinal fluid protein and glucose concentrations did not change significantly after 30 days.

Conclusion: Patients with tuberculosis meningitis should be closely monitored clinical symptoms during the first month to assess treatment response. Lumbar puncture repeat should be performed after 30 days of treatment to assess treatment response based on cerebrospinal fluid leukocyte counts instead of protein and glucose concentrations.

References
[1]
Thwaites G, Fisher M, Hemingway C et al. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect, 2009, 59 (3), 167-187. Google Scholar
[2]
al-Deeb S.M, Yaqub B.A, Sharif H.S et al. Neurotuberculosis: a review. Clin Neurol Neurosurg, 1992, 94 Suppl, S30-33. Google Scholar
[3]
Christensen A.S.H, Andersen A.B, Thomsen V.O et al. Tuberculous meningitis in Denmark: a review of 50 cases. BMC Infectious Diseases, 2011, 11 (1), 1-6. Google Scholar
[4]
Hosoglu S, Geyik M.F, Balik I et al. Predictors of outcome in patients with tuberculous meningitis. Int J Tuberc Lung Dis, 2002, 6 (1), 64-70. Google Scholar
[5]
Nguyễn Thị Hà. Nhận xét bước đầu về kết quả phát hiện vi khuẩn lao của kỹ thuật PCR, MGIT, soi trực tiếp trong lao màng phổi, màng não. Tạp chí Y học thực hành, 2008, 7, tr. 3-4. Google Scholar
[6]
Bộ Y tế. Quyết định số 162/QĐ-BYT, ngày 19 tháng 01 năm 2024 về việc ban hành tài liệu chuyên môn “Hướng dẫn chẩn đoán, điều trị và dự phòng bệnh lao”. Google Scholar
[7]
Nguyễn Thị Hà. Nghiên cứu đặc điểm lâm sàng, cận lâm sàng của lao màng não ở người lớn theo giai đoạn bệnh. Luận văn thạc sĩ y học, Trường Đại học Y Hà Nội, 2009. Google Scholar
[8]
Trần Thị Tuấn Anh. Nghiên cứu đặc điểm lâm sàng và cận lâm sàng bệnh lao màng não người lớn. Trường Đại học Y Hà Nội, 2013. Google Scholar
[9]
Schoeman J.F, Elshof J.W, Laubscher J.A et al. The effect of adjuvant steroid treatment on serial cerebrospinal fluid changes in tuberculous meningitis. Ann Trop Paediatr, 2001, 21 (4), 299-305. Google Scholar
[10]
Patel V.B, Burger I, Connolly C. Temporal evolution of cerebrospinal fluid following initiation of treatment for tuberculous meningitis. S Afr Med J, 2008, 98 (8), 610-613. Google Scholar